Scott Gottlieb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Scott Gottlieb has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Lauren Silvis
Tempus Labs, Chicago, Illinois
2 shared publicationsMark B. McClellan
Duke-Margolis Center for Health Policy, Durham, NC, and Washington, DC
1 shared publication
Latest Publications
- 1 December 2023
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 4 (12) , e235460
Strategies for Regulating Disruptive Medical Technologies
This JAMA Forum discusses 3 regulatory lessons from the US Food and Drug Administration that could be used for regulating new medical devices and technologies, such as those that include artificial intelligence.
- 1 December 2023
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 4 (12) , e235460
Strategies for Regulating Disruptive Medical Technologies
This JAMA Forum discusses 3 regulatory lessons from the US Food and Drug Administration that could be used for regulating new medical devices and technologies, such as those that include artificial intelligence.
- 1 September 2023
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 4 (9) , e233909
How to Safely Integrate Large Language Models Into Health Care
This JAMA Forum discusses categories of artificial intelligence devices such as clinical decision support tools and large language models that are increasing being used in health care and the improvements needed to ensure the accuracy and rigor of these tools for patient use.
- 1 September 2023
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 4 (9) , e233909
How to Safely Integrate Large Language Models Into Health Care
This JAMA Forum discusses categories of artificial intelligence devices such as clinical decision support tools and large language models that are increasing being used in health care and the improvements needed to ensure the accuracy and rigor of these tools for patient use.
- 2 June 2023
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 4 (6) , e232300
Regulators Face Novel Challenges as Artificial Intelligence Tools Enter Medical Practice
This JAMA Forum discusses artificial intelligence tools and the regulatory challenges for global regulatory bodies, including the US Food and Drug Administration, in creating new policies to ensure the safety and efficacy of these tools for patients.
- 2 June 2023
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 4 (6) , e232300
Regulators Face Novel Challenges as Artificial Intelligence Tools Enter Medical Practice
This JAMA Forum discusses artificial intelligence tools and the regulatory challenges for global regulatory bodies, including the US Food and Drug Administration, in creating new policies to ensure the safety and efficacy of these tools for patients.
- 2 March 2023
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 4 (3) , e230639
Bringing Transparency and Rigor to Medicare Drug Pricing
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
- 2 March 2023
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 4 (3) , e230639
Bringing Transparency and Rigor to Medicare Drug Pricing
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
- 7 October 2022
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 3 (10) , e224449
Reforms Needed to Modernize the US Food and Drug Administration’s Oversight of Dietary Supplements, Cosmetics, and Diagnostic Tests
This JAMA Forum discusses long-awaited reforms that could modernize the US Food and Drug Administration’s regulatory processes, promote innovation, and provide US consumers greater assurance that the products they use are safe and reliable.
- 7 October 2022
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 3 (10) , e224449
Reforms Needed to Modernize the US Food and Drug Administration’s Oversight of Dietary Supplements, Cosmetics, and Diagnostic Tests
This JAMA Forum discusses long-awaited reforms that could modernize the US Food and Drug Administration’s regulatory processes, promote innovation, and provide US consumers greater assurance that the products they use are safe and reliable.
- 3 June 2022
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 3 (6) , e222542
Ensuring a Safe and Reliable Supply of Infant Formula in the US
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
- 3 June 2022
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 3 (6) , e222542
Ensuring a Safe and Reliable Supply of Infant Formula in the US
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
- 3 December 2021
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 2 (12) , e215190
FDA’s Policy Changes for COVID-19 At-Home Diagnostics—Implications for Addressing Other Infectious Diseases and Future Pandemics
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
- 3 December 2021
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 2 (12) , e215190
FDA’s Policy Changes for COVID-19 At-Home Diagnostics—Implications for Addressing Other Infectious Diseases and Future Pandemics
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
- 3 August 2021
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 2 (8) , e213223
The Need for a US National Clinical Trial Infrastructure in a Public Health Crisis
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
- 3 August 2021
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 2 (8) , e213223
The Need for a US National Clinical Trial Infrastructure in a Public Health Crisis
Explore the latest in national and global health policy, including health care pricing, delivery, access, quality, safety, equity, and reform.
- 1 April 2021
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 2 (4) , e211236
Evaluating Postmarket Vaccine Safety—Time to Consolidate This Mission at a Single Agency
- 1 April 2021
- Published by American Medical Association (AMA) in JAMA Health Forum
- Vol. 2 (4) , e211236
Evaluating Postmarket Vaccine Safety—Time to Consolidate This Mission at a Single Agency
- 12 March 2020
- Vol. 117 (1) , 9-10
Pot Legalization Makes Vaping Deadly.